The Clinical Trial Protocol of the Metrifonate in ALzheimer’s Trial (MALT)

Publisher： Karger

E-ISSN： 1421-9824|9|2|2-7

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.9, Iss.2, 1998-07, pp. : 2-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial1

By  

Dementia and Geriatric Cognitive Disorders, Vol. 10, Iss. 3, 1999-05 ,pp. : 237-244

Karger

Access to resources Recommend Favorite

A Placebo-Controlled Trial of Valproate for Agitation and Aggression in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 23, Iss. 2, 2006-12 ,pp. : 116-119

Karger

Access to resources Recommend Favorite

Validity of Different Linguistic Versions of the Alzheimer’s Disease Assessment Scale in an International Multicentre Alzheimer’s Disease Trial

By  

Dementia and Geriatric Cognitive Disorders, Vol. 10, Iss. 4, 1999-06 ,pp. : 269-277

Karger

Access to resources Recommend Favorite

The Pharmacological Basis for Metrifonate’s Favourable Tolerability in the Treatment of Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 9, Iss. 2, 1998-07 ,pp. : 15-19

Karger

Access to resources Recommend Favorite

A Double-Blind Placebo-Controlled Randomized Trial of Melissa officinalis Oil and Donepezil for the Treatment of Agitation in Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 31, Iss. 2, 2011-02 ,pp. : 158-164

Karger

Access to resources Recommend Favorite